Literature DB >> 2816305

Differentiation in medulloblastomas: correlation between the immunocytochemical demonstration of photoreceptor markers (S-antigen, rod-opsin) and the survival rate in 66 patients.

M Czerwionka1, H W Korf, O Hoffmann, H Busch, W Schachenmayr.   

Abstract

Biopsy specimens of 66 medulloblastomas were investigated by means of S-antigen and rod-opsin immunocytochemistry. The patients were operated between 1969 and 1988 and the medical records were retrospectively evaluated to correlate the immunocytochemical features of the tumors to the course of the disease. S-antigen- and rod-opsin-immunoreactive tumor cells were found in 19 out of 66 cases. Since in the normal non-neoplastic state immunoreactive S-antigen and rod-opsin are restricted to retinal photoreceptors and a class of pinealocytes derived from photoreceptor cells, the occurrence of these proteins in certain tumor cells of medulloblastomas suggests a differentiation of these cells along the photoreceptor cell lineage and allows the identification of a special subtype of medulloblastoma displaying photoreceptor-specific characteristics. This subtype appears to be closely related to retinoblastomas and pineal cell tumors. The incidence of this subtype corresponds to approximately 30% of all medulloblastomas. Correlation between the demonstration of immunoreactive S-antigen and rod-opsin and the course of the disease revealed a 10-year survival rate of 50.6% for patients with medulloblastomas displaying photoreceptor-specific characteristics and maximally 11% for patients suffering from medulloblastomas devoid of these markers. Although the statistical evaluation does not provide a significant result, the estimated P-value of 0.085 indicates a distinct trend toward a better prognosis for patients suffering from medulloblastomas with photoreceptor-specific features. The validity of this trend needs to be proven in further studies with a greater number of patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816305     DOI: 10.1007/BF00691290

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Opsin-like immunoreaction in the retinae and pineal organs of four mammalian species.

Authors:  H W Korf; R G Foster; P Ekström; J J Schalken
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

2.  Immunocytochemical demonstration of retinal S-antigen in the pineal organ of four mammalian species.

Authors:  H W Korf; M Møller; I Gery; J S Zigler; D C Klein
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  Isolation and purification of bovine rhodopsin.

Authors:  W J De Grip; F J Daemen; S L Bonting
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 4.  Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem.

Authors:  L J Rubinstein
Journal:  J Neurosurg       Date:  1985-06       Impact factor: 5.115

5.  A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.

Authors:  A J Caputy; D C McCullough; H J Manz; K Patterson; M K Hammock
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

6.  S-antigen-like immunoreactivity in a human pineocytoma.

Authors:  H W Korf; D C Klein; J S Zigler; I Gery; W Schachenmayr
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

7.  Immunocytochemical evidence of molecular photoreceptor markers in cerebellar medulloblastomas.

Authors:  H W Korf; M Czerwionka; J Reiner; W Schachenmayr; J J Schalken; W de Grip; I Gery
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

8.  Retinal S-antigen: immunocytochemical and immunochemical studies on distribution in animal photoreceptors and pineal organs.

Authors:  T van Veen; R Elofsson; H G Hartwig; I Gery; M Mochizuki; V Ceña; D C Klein
Journal:  Exp Biol       Date:  1986

9.  Retinal S-antigen immunoreactivity in medulloblastomas.

Authors:  J M Bonnin; E Perentes
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Divergent glial and neuronal differentiation in a cerebellar medulloblastoma in an organ culture system: in vitro occurrence of synaptic ribbons.

Authors:  M M Herman; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

View more
  8 in total

1.  Immunohistochemistry of primitive neuroectodermal tumors in infants with special emphasis on cytokeratin expression.

Authors:  T Grieshammer; C Zimmer; K T Vogeley
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Photoreceptor differentiation in cerebellar medulloblastoma: evidence for a functional photopigment and authentic S-antigen (arrestin).

Authors:  C M Kramm; H W Korf; M Czerwionka; W Schachenmayr; W J de Grip
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Authors:  Tenley C Archer; Elizabeth L Mahoney; Scott L Pomeroy
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

4.  Immunocytochemical demonstration of interphotoreceptor retinoid-binding protein in cerebellar medulloblastoma.

Authors:  H W Korf; B Korf; W Schachenmayr; G J Chader; B Wiggert
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Midline brain tumors in MSV-SV 40-transgenic mice originate from the pineal organ.

Authors:  W Götz; F Theuring; W Schachenmayr; H W Korf
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.

Authors:  T Maraziotis; E Perentes; E Karamitopoulou; Y Nakagawa; E C Gessaga; A Probst; A Frankfurter
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  CRX is a diagnostic marker of retinal and pineal lineage tumors.

Authors:  Sandro Santagata; Cecile L Maire; Ahmed Idbaih; Lars Geffers; Mick Correll; Kristina Holton; John Quackenbush; Keith L Ligon
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

8.  Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Authors:  Marcel Kool; Jan Koster; Jens Bunt; Nancy E Hasselt; Arjan Lakeman; Peter van Sluis; Dirk Troost; Netteke Schouten-van Meeteren; Huib N Caron; Jacqueline Cloos; Alan Mrsić; Bauke Ylstra; Wieslawa Grajkowska; Wolfgang Hartmann; Torsten Pietsch; David Ellison; Steven C Clifford; Rogier Versteeg
Journal:  PLoS One       Date:  2008-08-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.